en

PRODUCT DETAIL

SORTIS 5 mg žuvacie tablety

Code 21602
MA number 31/0533/10-S
Product Form: tbl mnd 30x5 mg (blis.PA-Al-PVC/Al-vinyl-akryl)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Mutual recognition procedure
Therapeutic Class: 31 - HYPOLIPIDAEMICA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10A Lipid modifying agents, plain
C10AA HMG CoA reductase inhibitors
C10AA05 Atorvastatin
Shelf life: 24
Container: blister PA-Al-PVC/Al vinyl acryl
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 02.08.2010
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_SORTIS tbl mnd_04.2023.pdf  
SPC: SPC_SORTIS tbl mnd_04.2023.pdf  
Safety feature Yes
Data update: 16.10.2018
eu-flag.png sk-flag.png